TRANSMEDICS GROUP, INC.
TRANSMEDICS GROUP, INC.
ANDOVER, MA
Loading...
Price History
Market Data
| Market Cap | 3.29B |
| P/E Ratio | 19.71 |
| P/B Ratio | 6.96 |
| EPS | 4.87 |
| Dividend Yield | - |
| D/E Ratio | 1.26 |
| Current Ratio | 7.14 |
| Currency | USD |
Key Financial Metrics
605.49M
Revenue
190.29M
Net Income
4.87
EPS (Diluted)
156.34M
Free Cash Flow
Profitability
Gross Margin
59.9%
Operating Margin
17.9%
Net Profit Margin
31.4%
EBITDA
154.77M
Returns & Efficiency
Return on Assets (ROA)
17.8%
Return on Equity (ROE)
40.2%
Dividend Yield
-
EPS
4.87
Financial Health
Total Assets
1.07B
Total Debt
-
Debt to Equity
1.26x
Current Ratio
7.14
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Net Value:
-2.35M
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Measuring, Analyzing & Controlling Instruments |
| HQ | ANDOVER, MA |
| Fiscal Year | 2025 |
Peers
100.03B
P/E: --
MEDTRONIC PLC
MDT
100.03B
P/E: --
MASIMO CORP
MASI
6.99B
P/E: --
LIVANOVA PLC
LIVN
3.21B
P/E: --
2.92B
P/E: 35.5
LECTEC CORP /MN/
AXGN
2.32B
P/E: --
AXOGEN, INC.
AXGN
2.32B
P/E: --
CAPNIA, INC.
SLNO
2.04B
P/E: 77.1
Quick Links
Financial Statistics
Valuation
Market Cap$3.29B
P/E Ratio (TTM)19.7
Price to Book6.96
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin59.9%
Operating Margin17.9%
Net Margin31.4%
ROE40.2%
ROA17.8%
Leverage & Liquidity
Debt to Equity1.26
Current Ratio7.14
Total Debt-
Total Assets$1.07B
Stockholders' Equity$473.10M
Income Statement (FY 2025)
Revenue$605.49M
Gross Profit$362.81M
Operating Income$108.58M
Net Income$190.29M
EPS (Diluted)$4.87
Cash Flow (FY 2025)
Free Cash Flow$156.34M
Cash & Equivalents$488.37M
Revenue Growth37.1%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 200 MINUTEMAN ROAD ANDOVER, MA 01810 |
| Phone | 9785520900 |
| Incorporated | MA, US |
| EIN | 000000000 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 34.30M |
| Stockholders' Equity | $473.10M |
| Cash & Equivalents | $488.37M |
Recent Filings
View All
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-10
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-10
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-04
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-27
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-24
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-24
Local
3
Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-02-12
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | TRANSMEDICS GROUP, INC. |
| Ticker | TMDX |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Measuring, Analyzing & Controlling Instruments |
| Headquarters | ANDOVER, MA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 3.29B |
| Revenue | 605.49M |
| Net Income | 190.29M |
| P/E Ratio | 19.71 |
| EPS | 4.87 |
| Net Margin | 31.4% |
| ROE | 40.2% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...